Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | hypothetical protein | 0.0456 | 0.3409 | 0.3409 |
Trypanosoma brucei | hypothetical protein, conserved | 0.0456 | 0.3409 | 1 |
Schistosoma mansoni | fusion | 0.0456 | 0.3409 | 0.3409 |
Leishmania major | hypothetical protein, conserved | 0.0456 | 0.3409 | 1 |
Mycobacterium leprae | Probable lipase LipE | 0.0029 | 0 | 0.5 |
Trypanosoma cruzi | Zn-finger in Ran binding protein and others, putative | 0.0456 | 0.3409 | 1 |
Toxoplasma gondii | ran binding protein | 0.0456 | 0.3409 | 0.3409 |
Schistosoma mansoni | cellular tumor antigen P53 | 0.0148 | 0.0951 | 0.0951 |
Echinococcus multilocularis | ring and YY1 binding protein | 0.0456 | 0.3409 | 0.3409 |
Echinococcus multilocularis | zinc finger protein Ran binding | 0.0456 | 0.3409 | 0.3409 |
Echinococcus granulosus | ring and YY1 binding protein | 0.0456 | 0.3409 | 0.3409 |
Schistosoma mansoni | RNA binding protein | 0.0456 | 0.3409 | 0.3409 |
Echinococcus multilocularis | Nuclear pore complex protein Nup153 | 0.0456 | 0.3409 | 0.3409 |
Loa Loa (eye worm) | hypothetical protein | 0.0456 | 0.3409 | 0.3409 |
Mycobacterium ulcerans | fusion of enoyl-CoA hydratase, EchA21 and lipase, LipE | 0.0029 | 0 | 0.5 |
Trypanosoma cruzi | WLM domain containing protein, putative | 0.0456 | 0.3409 | 1 |
Echinococcus granulosus | Nuclear pore complex protein Nup153 | 0.0456 | 0.3409 | 0.3409 |
Brugia malayi | YY1-associated factor 2 | 0.0456 | 0.3409 | 0.3409 |
Loa Loa (eye worm) | hypothetical protein | 0.0456 | 0.3409 | 0.3409 |
Schistosoma mansoni | brg-1 associated factor | 0.1282 | 1 | 1 |
Onchocerca volvulus | 0.0148 | 0.0951 | 0.0951 | |
Echinococcus granulosus | zinc finger protein Ran binding | 0.0456 | 0.3409 | 0.3409 |
Schistosoma mansoni | hypothetical protein | 0.1282 | 1 | 1 |
Toxoplasma gondii | Zn-finger in Ran binding protein and others domain-containing protein | 0.0456 | 0.3409 | 0.3409 |
Echinococcus granulosus | SWI:SNF matrix associated | 0.1282 | 1 | 1 |
Chlamydia trachomatis | DNA topoisomerase I | 0.1282 | 1 | 0.5 |
Schistosoma mansoni | zinc finger protein | 0.0456 | 0.3409 | 0.3409 |
Loa Loa (eye worm) | hypothetical protein | 0.0456 | 0.3409 | 0.3409 |
Plasmodium falciparum | SWIB/MDM2 domain-containing protein | 0.1282 | 1 | 1 |
Onchocerca volvulus | 0.1282 | 1 | 1 | |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0456 | 0.3409 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0148 | 0.0951 | 0.0951 |
Mycobacterium ulcerans | esterase/lipase LipP | 0.0029 | 0 | 0.5 |
Mycobacterium ulcerans | beta-lactamase | 0.0029 | 0 | 0.5 |
Mycobacterium ulcerans | hypothetical protein | 0.0029 | 0 | 0.5 |
Echinococcus multilocularis | SWI:SNF matrix associated | 0.1282 | 1 | 1 |
Schistosoma mansoni | hypothetical protein | 0.1282 | 1 | 1 |
Echinococcus multilocularis | Upstream activation factor subunit UAF30 | 0.1282 | 1 | 1 |
Trypanosoma cruzi | WLM domain containing protein, putative | 0.0456 | 0.3409 | 1 |
Echinococcus granulosus | Zinc finger RanBP2 type | 0.0456 | 0.3409 | 0.3409 |
Loa Loa (eye worm) | hypothetical protein | 0.0456 | 0.3409 | 0.3409 |
Trichomonas vaginalis | set domain proteins, putative | 0.0189 | 0.1281 | 0.1281 |
Plasmodium vivax | hypothetical protein, conserved | 0.1282 | 1 | 1 |
Echinococcus multilocularis | tumor protein p63 | 0.1011 | 0.784 | 0.784 |
Brugia malayi | Zn-finger in Ran binding protein and others containing protein | 0.0456 | 0.3409 | 0.3409 |
Onchocerca volvulus | 0.0189 | 0.1281 | 0.1281 | |
Mycobacterium tuberculosis | Possible penicillin-binding protein | 0.0184 | 0.1238 | 1 |
Onchocerca volvulus | 0.0456 | 0.3409 | 0.3409 | |
Onchocerca volvulus | 0.0456 | 0.3409 | 0.3409 | |
Toxoplasma gondii | SWIB/MDM2 domain-containing protein | 0.1282 | 1 | 1 |
Onchocerca volvulus | Ubiquitin thioesterase ZRANB1 homolog | 0.0456 | 0.3409 | 0.3409 |
Brugia malayi | Zn-finger in Ran binding protein and others containing protein | 0.0456 | 0.3409 | 0.3409 |
Leishmania major | hypothetical protein, conserved | 0.0456 | 0.3409 | 1 |
Trypanosoma cruzi | mitochondrial RNA binding complex 1 subunit, putative | 0.0456 | 0.3409 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.1282 | 1 | 1 |
Echinococcus granulosus | Upstream activation factor subunit UAF30 | 0.1282 | 1 | 1 |
Leishmania major | hypothetical protein, conserved | 0.0456 | 0.3409 | 1 |
Loa Loa (eye worm) | pre-SET domain-containing protein family protein | 0.0166 | 0.1098 | 0.1098 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0456 | 0.3409 | 1 |
Trypanosoma cruzi | Zn-finger in Ran binding protein and others, putative | 0.0456 | 0.3409 | 1 |
Schistosoma mansoni | TRABID protein (C64 family) | 0.0456 | 0.3409 | 0.3409 |
Brugia malayi | Zn-finger in Ran binding protein and others containing protein | 0.0456 | 0.3409 | 0.3409 |
Chlamydia trachomatis | SWIB complex protein | 0.1282 | 1 | 0.5 |
Loa Loa (eye worm) | brahma associated protein | 0.1282 | 1 | 1 |
Onchocerca volvulus | 0.0456 | 0.3409 | 0.3409 | |
Plasmodium vivax | SWIB/MDM2 domain-containing protein, putative | 0.1282 | 1 | 1 |
Brugia malayi | Pre-SET motif family protein | 0.0166 | 0.1098 | 0.1098 |
Brugia malayi | Zn-finger in Ran binding protein and others containing protein | 0.0456 | 0.3409 | 0.3409 |
Leishmania major | hypothetical protein, conserved | 0.0456 | 0.3409 | 1 |
Trypanosoma cruzi | mitochondrial RNA binding complex 1 subunit, putative | 0.0456 | 0.3409 | 1 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0456 | 0.3409 | 1 |
Loa Loa (eye worm) | SWIB/MDM2 domain-containing protein | 0.1282 | 1 | 1 |
Mycobacterium ulcerans | lipase LipD | 0.0029 | 0 | 0.5 |
Echinococcus multilocularis | Zinc finger, RanBP2 type | 0.0456 | 0.3409 | 0.3409 |
Trypanosoma brucei | hypothetical protein, conserved | 0.0456 | 0.3409 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0456 | 0.3409 | 0.3409 |
Echinococcus granulosus | tumor protein p63 | 0.1011 | 0.784 | 0.784 |
Trypanosoma cruzi | Zn-finger in Ran binding protein and others/FYVE zinc finger, putative | 0.0456 | 0.3409 | 1 |
Leishmania major | hypothetical protein, conserved | 0.0456 | 0.3409 | 1 |
Onchocerca volvulus | 0.0456 | 0.3409 | 0.3409 | |
Schistosoma mansoni | hypothetical protein | 0.1282 | 1 | 1 |
Brugia malayi | brahma associated protein 60 kDa | 0.1282 | 1 | 1 |
Echinococcus multilocularis | SWI:SNF matrix associated | 0.1282 | 1 | 1 |
Trypanosoma brucei | mitochondrial RNA binding complex 1 subunit | 0.0456 | 0.3409 | 1 |
Trypanosoma brucei | Zn-finger in Ran binding protein and others/FYVE zinc finger, putative | 0.0456 | 0.3409 | 1 |
Plasmodium falciparum | SWIB/MDM2 domain-containing protein | 0.1282 | 1 | 1 |
Brugia malayi | SWIB/MDM2 domain containing protein | 0.1282 | 1 | 1 |
Toxoplasma gondii | DNA topoisomerase domain-containing protein | 0.1282 | 1 | 1 |
Echinococcus multilocularis | SWI:SNF matrix associated | 0.1282 | 1 | 1 |
Mycobacterium leprae | conserved hypothetical protein | 0.0029 | 0 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = -4 | Ability to inhibit HMG-CoA reductase (HMGR) by cholesterol synthesis inhibition screen (CSI) in rats | ChEMBL. | 2296019 |
IC50 (binding) | > 100 uM | Ability to inhibit HMG-CoA reductase (HMGR) by cholesterol synthesis inhibition screen (CSI) in rats | ChEMBL. | 2296019 |
IC50 (binding) | > 100 uM | Ability to inhibit HMG-CoA reductase (HMGR) by cholesterol synthesis inhibition screen (CSI) in rats | ChEMBL. | 2296019 |
Log IC50 (binding) | = -4 | Ability to inhibit HMG-CoA reductase (HMGR) by cholesterol synthesis inhibition screen (CSI) in rats | ChEMBL. | 2296019 |
Relative potency (binding) | < 0.01 | Ratio of inhibitory activity of compound against HMG-CoA reductase to that of compactin | ChEMBL. | 2296019 |
Relative potency (binding) | < 0.01 | Ratio of inhibitory activity of compound against HMG-CoA reductase to that of compactin | ChEMBL. | 2296019 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.